Implementation and evaluation of an oncology-specific trigger tool for detecting adverse drug reactions in hospitalized patients: a prospective observational study
Romanian Journal of Medical Practice · 31.03.2026 · 21 (1) · 21
DOI: 10.37897/rjmp.2026.1.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Medical Practice, online erschienen am 31.03.2026. Verfasst von Priscilla Mary und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
To implement an oncology-specific trigger tool for the systematic identification of adverse drug reactions (ADRs) in hospitalized patients receiving antineoplastic therapy and to evaluate trigger yield and positive predictive value. Materials and methods. This prospective observational study was conducted over six months in a tertiary care teaching hospital in Coimbatore, India. A locally adapted 48-item oncology-specific trigger tool comprising laboratory, medication, symptom/clinical, and intervention triggers was used to screen adult oncology inpatients receiving chemotherapy with or without radiotherapy. Each trigger occurrence prompted focused chart review. Trigger-linked events fulfilling the study definition of an ADR were treated as confirmed ADR signals, and overlapping signals referring to the same clinical event were consolidated into unique ADR episodes. A clinical pharmacist, in consultation with an oncologist, confirmed ADRs and classified them using CTCAE v5.0 for severity, the Naranjo algorithm for causality, Type A/Type B criteria for predictability, and Schumock–Thornton criteria for preventability.
Results
Among 225 hospitalized oncology patients, 1125 trigger occurrences were identified. Review of trigger-positive records confirmed 471 ADR signals, corresponding to an overall positive predictive value of 41.9%. At the patient level, 151 patients (67.1%) experienced at least one confirmed ADR. After consolidation of overlapping trigger-linked signals, 342 unique ADR episodes were identified. Hematological toxicities were the most common (228/342, 66.7%), followed by gastrointestinal events (77/342, 22.5%). Most ADR episodes were CTCAE Grade 2 (191/342, 55.8%), while Grade 3 and Grade 4 events accounted for 20.8% and 2.9%, respectively. On causality assessment, most ADRs were classified as probable (235/342, 68.7%), and 62.0% were considered probably preventable.
Conclusions
An oncology-specific trigger tool enabled systematic detection and characterization of ADRs in hospitalized patients receiving antineoplastic therapy, with moderate overall positive predictive value and particularly high yield for several hematology-related and intervention-based triggers. Refinement of lower-specificity triggers and integration of trigger-based review into routine inpatient oncology pharmacovigilance may improve the timeliness and efficiency of ADR detection and support safer clinical management.
Zitieren
APA
Mary, P., Adhithiya, S., Balaji, D., Selvaraj, H., Manivannan, P., & Dharini, B. (2026). Implementation and evaluation of an oncology-specific trigger tool for detecting adverse drug reactions in hospitalized patients: a prospective observational study. Romanian Journal of Medical Practice, 21(1), 21. https://doi.org/10.37897/rjmp.2026.1.3
Vancouver
Mary P, Adhithiya S, Balaji D, Selvaraj H, Manivannan P, Dharini B. Implementation and evaluation of an oncology-specific trigger tool for detecting adverse drug reactions in hospitalized patients: a prospective observational study. Romanian Journal of Medical Practice. 2026;21(1):21. doi:10.37897/rjmp.2026.1.3
BibTeX
@article{Mary2026,
author = {Mary, Priscilla and Adhithiya, S. and Balaji, D. and Selvaraj, Hemalatha and Manivannan, P. and Dharini, B.},
title = {Implementation and evaluation of an oncology-specific trigger tool for detecting adverse drug reactions in hospitalized patients: a prospective observational study},
journal = {Romanian Journal of Medical Practice},
year = {2026},
volume = {21},
number = {1},
pages = {21},
doi = {10.37897/rjmp.2026.1.3}
}
EUVIMED